Valeo Financial Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.06M | Buy |
8,367
+576
| +7% | +$75.9K | 0.02% | 300 |
|
|
2026
Q1 | $1.09M | Sell |
7,791
-5,443
| -41% | -$762K | 0.03% | 260 |
|
|
2025
Q4 | $1.62M | Buy |
13,234
+107
| +0.8% | +$13K | 0.04% | 201 |
|
|
2025
Q3 | $1.46M | Sell |
13,127
-151
| -1% | -$17.2K | 0.03% | 217 |
|
|
2025
Q2 | $1.47M | Buy |
13,278
+2,811
| +27% | +$299K | 0.04% | 210 |
|
|
2025
Q1 | $1.17M | Buy |
10,467
+883
| +9% | +$91.1K | 0.03% | 232 |
|
|
2024
Q4 | $885K | Buy |
9,584
+45
| +0.5% | +$4.05K | 0.02% | 291 |
|
|
2024
Q3 | $800K | Buy |
9,539
+1,070
| +13% | +$81.6K | 0.02% | 305 |
|
|
2024
Q2 | $581K | Sell |
8,469
-294
| -3% | -$19.6K | 0.02% | 349 |
|
|
2024
Q1 | $588K | Buy |
8,763
+1,400
| +19% | +$108K | 0.02% | 329 |
|
|
2023
Q4 | $596K | Buy |
7,363
+491
| +7% | +$38.2K | 0.02% | 313 |
|
|
2023
Q3 | $515K | Sell |
6,872
-1,979
| -22% | -$152K | 0.02% | 324 |
|
|
2023
Q2 | $682K | Buy |
8,851
+674
| +8% | +$53.8K | 0.03% | 257 |
|
|
2023
Q1 | $678K | Buy |
8,177
+1,031
| +14% | +$85.4K | 0.03% | 276 |
|
|
2022
Q4 | $614K | Buy |
7,146
+2,873
| +67% | +$228K | 0.03% | 249 |
|
|
2022
Q3 | $264K | Buy |
4,273
+93
| +2% | +$5.86K | 0.02% | 381 |
|
|
2022
Q2 | $258K | Sell |
4,180
-3,669
| -47% | -$227K | 0.02% | 385 |
|
|
2022
Q1 | $467K | Buy |
7,849
+189
| +2% | +$12.1K | 0.02% | 342 |
|
|
2021
Q4 | $556K | Buy |
7,660
+426
| +6% | +$29.3K | 0.03% | 282 |
|
|
2021
Q3 | $505K | Buy |
7,234
+1,038
| +17% | +$72.9K | 0.03% | 300 |
|
|
2021
Q2 | $427K | Buy |
6,196
+2,213
| +56% | +$148K | 0.03% | 287 |
|
|
2021
Q1 | $257K | Buy |
3,983
+1,447
| +57% | +$93.3K | 0.01% | 384 |
|
|
2020
Q4 | $148K | Sell |
2,536
-1,043
| -29% | -$62.9K | 0.01% | 477 |
|
|
2020
Q3 | $226K | Sell |
3,579
-1,898
| -35% | -$132K | 0.02% | 303 |
|
|
2020
Q2 | $421K | Buy |
5,477
+1,241
| +29% | +$95.1K | 0.04% | 205 |
|
|
2020
Q1 | $312K | Buy |
4,236
+1,066
| +34% | +$73.7K | 0.03% | 223 |
|
|
2019
Q4 | $206K | Sell |
3,170
-949
| -23% | -$61.8K | 0.02% | 318 |
|
|
2019
Q3 | $261K | Buy |
4,119
+129
| +3% | +$8.43K | 0.03% | 245 |
|
|
2019
Q2 | $270K | Sell |
3,990
-516
| -11% | -$33.9K | 0.03% | 233 |
|
|
2019
Q1 | $293K | Sell |
4,506
-12,907
| -74% | -$858K | 0.04% | 221 |
|
|
2018
Q4 | $1.09M | Sell |
17,413
-4,341
| -20% | -$303K | 0.15% | 103 |
|
|
2018
Q3 | $1.49M | Sell |
21,754
-430
| -2% | -$32.5K | 0.2% | 84 |
|
|
2018
Q2 | $1.71M | Sell |
22,184
-12,762
| -37% | -$901K | 0.24% | 70 |
|
|
2018
Q1 | $2.63M | Sell |
34,946
-536
| -2% | -$42.6K | 0.42% | 47 |
|
|
2017
Q4 | $2.54M | Buy |
35,482
+5,735
| +19% | +$436K | 0.42% | 51 |
|
|
2017
Q3 | $2.41M | Buy |
+29,747
| New | +$2.27M | 0.55% | 43 |
|
Other funds holding GILD
Valeo Financial Advisors's GILD Position: Q2 2026 in Review
Valeo Financial Advisors increased its Gilead Sciences (GILD) stake by 7.4% in Q2 2026, buying an estimated $75.9K and bringing the position to 8,367 shares worth $1.06M. The position accounts for 0.02% of the portfolio, ranked #300.
Valeo Financial Advisors first reported a position in GILD in Q3 2017 and has held it in 36 quarters since. The position peaked at $2.63M in Q1 2018. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Valeo Financial Advisors held 8,367 shares of Gilead Sciences worth $1.06M as of Q2 2026.
- Valeo Financial Advisors bought 576 Gilead Sciences shares in Q2 2026, an estimated $75.9K.
- Gilead Sciences made up 0.02% of Valeo Financial Advisors's portfolio in Q2 2026, its #300 holding.
- Valeo Financial Advisors first reported a position in Gilead Sciences in Q3 2017 and has held it in 36 quarters since.
- Valeo Financial Advisors's Gilead Sciences position peaked at $2.63M in Q1 2018.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Valeo Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.